Pain relief, no opioids: Mass. biotech gets NIH grant for new drug

Months after launching publicly with $26 million in venture funding, biotech startup 1910 Genetics has inked its first government contract. The startup will explore non-opioid pain relief with the help of a $550,000 grant through the National Institutes of Health’s Small Business Technology Transfer program.